These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3867786)

  • 1. Diuretic therapy in uremic patients.
    Dal Canton A; Russo D; Gallo R; Ardillo G; Trevico S; Cianciaruso B; Andreucci VE
    Kidney Int Suppl; 1985 Dec; 17():S154-6. PubMed ID: 3867786
    [No Abstract]   [Full Text] [Related]  

  • 2. Muzolimine in chronic renal failure: a study in 16 patients.
    Stratta P; Dogliani M; Squiccimarro G; Colla L; Vercellone A
    Z Kardiol; 1985; 74 Suppl 2():125-8. PubMed ID: 4002786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muzolimine in advanced chronic renal failure.
    Mastrangelo F; Rizzelli S; Corlianò C; Alfonso L; De Blasi V; Aprile M; Montinaro AM; Napoli M
    Z Kardiol; 1985; 74 Suppl 2():109-14. PubMed ID: 4002783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New trends in diuretic therapy. 3rd International Edrul Symposium.
    Z Kardiol; 1985; 74 Suppl 2():1-193. PubMed ID: 4002780
    [No Abstract]   [Full Text] [Related]  

  • 5. [Success of muzolimine in the treatment of refractory edema syndromes].
    Hannedouche T; Fillastre JP
    Presse Med; 1986 Apr; 15(17):802. PubMed ID: 2940531
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of muzolimine and furosemide in heart failure.
    Salerno M; Di Salvo M; Furnari R; Vaccaro F; Licciardi S; Finocchiaro S
    Z Kardiol; 1985; 74 Suppl 2():32-3. PubMed ID: 4002801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease.
    Dal Canton A; Russo D; Gallo R; Conte G; Andreucci VE
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):595-8. PubMed ID: 6781585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
    Morachiello P; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Bazzato G
    Z Kardiol; 1985; 74 Suppl 2():115-20. PubMed ID: 4002784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term, high-dose muzolimine treatment in patients with chronic renal failure and acute fluid retention.
    Orsoni G; Di Felice A; Hadjigavriel M; Biavati M; Bonomini V
    Z Kardiol; 1985; 74 Suppl 2():121-4. PubMed ID: 4002785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.
    Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Forte M; Morachiello P
    Z Kardiol; 1985; 74 Suppl 2():92-5. PubMed ID: 4002811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
    Baumelou A; Singlas E; Ritter W; Merdjan H; Martre H; Brouard R; Chickh-Touami C; Patte R
    Z Kardiol; 1985; 74 Suppl 2():88-91. PubMed ID: 4002810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of muzolimine and furosemide in patients with end-stage renal failure on chronic dialysis.
    Schmidt P; Loew D; Dycka J; Kopsa H; Balcke P; Zazgornik J; Deutsch E
    Eur J Clin Pharmacol; 1981; 20(1):23-6. PubMed ID: 7308268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacodynamic and pharmacokinetic studies of muzolimine in patients with hepatogeneous ascites (author's transl)].
    Loew D; Dýcka J; Pfleiderer T; Ritter W
    Z Gastroenterol; 1980 Oct; 18(10):537-42. PubMed ID: 7456563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muzolimine in patients on chronic hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD).
    Bandiani G; Camaiora E; Nicolini MA; Perotta U
    Z Kardiol; 1985; 74 Suppl 2():84-7. PubMed ID: 4002809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of muzolimine and of a combination of hydrochlorothiazide/triamterene in healthy subjects and in nephrotic patients.
    Riechers G; Futerova M; Hanisch M; Ritter W; Kühn K
    Z Kardiol; 1985; 74 Suppl 2():103-8. PubMed ID: 4002782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of muzolimine in postischemic acute renal failure in rats.
    Garthoff B
    Z Kardiol; 1985; 74 Suppl 2():171-4. PubMed ID: 4002795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
    Storstein L; Bjørnstad H; Mølstad P
    Z Kardiol; 1985; 74 Suppl 2():34-6. PubMed ID: 4002802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-dosing metolazone with loop diuretic combination regimens.
    Lorenz RA; Elwell RJ
    Nephrol Nurs J; 2006; 33(1):78-9. PubMed ID: 16538931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.